Jeroen van Beek
2021 - Allovir
In 2021, Jeroen van Beek earned a total compensation of $4.2M as Chief Commercial Officer at Allovir.
Compensation breakdown
| Non-Equity Incentive Plan | $170,000 |
|---|---|
| Option Awards | $2,096,599 |
| Salary | $425,000 |
| Stock Awards | $1,475,250 |
| Other | $6,000 |
| Total | $4,172,849 |
van Beek received $2.1M in option awards, accounting for 50% of the total pay in 2021.
van Beek also received $170K in non-equity incentive plan, $425K in salary, $1.5M in stock awards and $6K in other compensation.
Rankings
In 2021, Jeroen van Beek's compensation ranked 3,199th out of 12,415 executives tracked by ExecPay. In other words, van Beek earned more than 74.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,199 out of 12,415 | 74th |
Division Manufacturing | 1,294 out of 5,505 | 77th |
Major group Chemicals And Allied Products | 528 out of 2,375 | 78th |
Industry group Drugs | 469 out of 2,096 | 78th |
Industry Biological Products, Except Diagnostic Substances | 128 out of 449 | 72nd |
Source: SEC filing on April 6, 2022.
van Beek's colleagues
We found four more compensation records of executives who worked with Jeroen van Beek at Allovir in 2021.